Prescription medicine
Hemin Brand names: Panhematin
Hemin (Panhematin) is a prescription medicine. No generic is listed in FDA's NDC Directory.
- No generic listed
Check it at the source: the hemin FDA label on DailyMed (effective February 26, 2026); every hemin label on DailyMed.
Highlights of the record
FDA label of February 26, 2026; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026
Used for
From the label: indications and usagePANHEMATIN is a hemin for injection indicated for the amelioration of recurrent attacks of acute intermittent porphyria temporally related to the menstrual cycle in susceptible women, after initial carbohydrate therapy is known or suspected to be inadequate.
Forms and strengths
- 7 mg/ml
Powder for solution.
On the market
- Generic approvals
- No generic approved
- Labelers listed (NDC)
- 1 of which 0 under generic applications, 1 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- Not in the survey
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- No recall recorded
- FAERS reports
- 546 through July 30, 2026
What is hemin used for?
From the label: indications and usagePANHEMATIN is a hemin for injection indicated for the amelioration of recurrent attacks of acute intermittent porphyria temporally related to the menstrual cycle in susceptible women, after initial carbohydrate therapy is known or suspected to be inadequate. Limitations of Use
Before administering PANHEMATIN, consider an appropriate period of carbohydrate loading (i.e., 400 g glucose/day for 1 to 2 days) [ See Dosage and Administration ( 2.1 ) ].
Attacks of porphyria may progress to a point where irreversible neuronal damage has occurred. PANHEMATIN therapy is intended to prevent an attack from reaching the critical stage of neuronal degeneration. […]
Source: FDA drug label (Panhematin), Recordati Rare Diseases, Inc., effective February 26, 2026 (SPL set 9984267a-4d57-4444-9bb5-16bca7dea691), via openFDA; the full label on DailyMed
Is there a generic for hemin (Panhematin)?
No generic hemin is approved (Drugs@FDA, October 8, 2026).
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
What do FAERS reports show for hemin?
The FDA Adverse Event Reporting System holds 546 reports that list hemin among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 20 are coded as a death and 168 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
Reports received each year
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What next?
- Hemin side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other